Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders

Overweight and obesity lead to an increased risk for metabolic disorders such as impaired glucose regulation/insulin resistance, dyslipidemia, and hypertension. Several molecular drug targets with potential to prevent or treat metabolic disorders have been revealed. Interestingly, the activation of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Min-Chul Cho, Kyoung Lee, Sang-Gi Paik, Do-Young Yoon
Format:	Article
Language:	English
Published:	Wiley 2008-01-01
Series:	PPAR Research
Online Access:	http://dx.doi.org/10.1155/2008/679137
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Peroxisome proliferator‐activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut
by: Mathurin Fumery, et al.
Published: (2017-09-01)

Examination of Ligand-Dependent Coactivator Recruitment by Peroxisome Proliferator-Activated Receptor-α (PPARα)
by: Eric S. Tien, et al.
Published: (2006-01-01)

Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions
by: Salvatore Giovanni Vitale, et al.
Published: (2016-01-01)

Peroxisome Proliferator Activator Receptor (PPAR)-γ Ligand, but Not PPAR-α, Ameliorates Cyclophosphamide-Induced Oxidative Stress and Inflammation in Rat Liver
by: Azza A. K. El-Sheikh, et al.
Published: (2014-01-01)

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor
by: K. Hashizume, et al.
Published: (2008-01-01)

Pharmacological inhibition of Peroxisome Proliferation-Activated Receptor Delta (PPARδ) imparts selective leukemia cell death
by: Yingying Yang, et al.
Published: (2025-07-01)

New Target Genes for the Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Antitumour Activity: Perspectives from the Insulin Receptor
by: Daniela P. Foti, et al.
Published: (2009-01-01)

Association of Peroxisome Proliferator-Activated Receptors (PPARs) with Diabetic Retinopathy in Human and Animal Models: Analysis of the Literature and Genome Browsers
by: Špela Tajnšek, et al.
Published: (2020-01-01)

Peroxisome Proliferator-Activated Receptors and Shock State
by: Emanuela Esposito, et al.
Published: (2006-01-01)

Oleic acid promotes lipid accumulation in bovine adipocytes: the role of peroxisome proliferator-activated receptor alpha (PPARα) signaling
by: U. Abou-Rjeileh, et al.
Published: (2025-05-01)

Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver
by: Yun-Xia Zhu, et al.
Published: (2016-01-01)

Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
by: Dingzhi Wang, et al.
Published: (2008-01-01)

Peroxisome Proliferator-Activated Receptors in HBV-Related Infection
by: Laurent Dubuquoy, et al.
Published: (2009-01-01)

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
by: Sébastien Dharancy, et al.
Published: (2009-01-01)

The Role of Peroxisome Proliferator-Activated Receptor β/δ on the Inflammatory Basis of Metabolic Disease
by: Teresa Coll, et al.
Published: (2010-01-01)

Peroxisome proliferator‐activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target
by: Oren Pleniceanu, et al.
Published: (2017-03-01)

Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARγ), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats
by: Chia Yoke Yin, et al.
Published: (2010-01-01)

Peroxisome Proliferator-Activated Receptor-γ Is Critical to Cardiac Fibrosis
by: Huang-Jun Liu, et al.
Published: (2016-01-01)

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma
by: Oxana Yu. Kytikova, et al.
Published: (2020-01-01)

Role of Peroxisome Proliferator-Activated Receptor γ in Ocular Diseases
by: Su Zhang, et al.
Published: (2015-01-01)

Role of Peroxisome Proliferator-Activated Receptor-γ in Vascular Inflammation
by: Kousei Ohshima, et al.
Published: (2012-01-01)

Peroxisome Proliferator-Activated Receptor -β/δ, -γ Agonists and Resveratrol Modulate Hypoxia Induced Changes in Nuclear Receptor Activators of Muscle Oxidative Metabolism
by: Timothy R. H. Regnault, et al.
Published: (2010-01-01)

Pemafibrate modulates peroxisome proliferator-activated receptor alpha and prevents alcohol-associated liver disease in rats
by: Takashi Saito, et al.
Published: (2025-04-01)

Activation of β-Adrenoceptors by Dobutamine May Induce a Higher Expression of Peroxisome Proliferator-Activated Receptors δ (PPARδ) in Neonatal Rat Cardiomyocytes
by: Ming-Ting Chou, et al.
Published: (2012-01-01)

Regulation of Peroxisome Proliferator-Activated Receptors by E6-Associated Protein
by: Lakshmi Gopinathan, et al.
Published: (2008-01-01)

The Role of Peroxisome Proliferator-Activated Receptors in the Esophageal, Gastric, and Colorectal Cancer
by: Alessandra Fucci, et al.
Published: (2012-01-01)

Nuclear Control of the Inflammatory Response in Mammals by Peroxisome Proliferator-Activated Receptors
by: Stéphane Mandard, et al.
Published: (2013-01-01)

Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
by: Nan Wang, et al.
Published: (2017-01-01)

Exploring the Role of Peroxisome Proliferator-Activated Receptors and Endothelial Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Ana Paula Madariaga Traconis, et al.
Published: (2024-12-01)

Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects
by: Zijun Wu, et al.
Published: (2026-04-01)

Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template
by: Hiroyuki Miyachi, et al.
Published: (2008-01-01)

The Role of Peroxisome Proliferator-Activated Receptors in the Development and Physiology of Gametes and Preimplantation Embryos
by: Jaou-Chen Huang
Published: (2008-01-01)

Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
by: Claire B. Pollock, et al.
Published: (2010-01-01)

The Versatile Role of Peroxisome Proliferator-Activated Receptors in Immune-Mediated Intestinal Diseases
by: Edit Posta, et al.
Published: (2024-10-01)

Peptide Helix-Y12 as Potential Effector for Peroxisome Proliferator-Activated Receptors
by: Mauricio Carrillo-Tripp, et al.
Published: (2023-01-01)

Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors
by: Tengis S. Pavlov, et al.
Published: (2010-01-01)

Activating Effect of Benzbromarone, a Uricosuric Drug, on Peroxisome Proliferator-Activated Receptors
by: Chiyoko Kunishima, et al.
Published: (2007-01-01)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ.
by: David L McCormick, et al.
Published: (2015-01-01)

Evaluation of C-X-C chemokine receptor type 4 (CXCR4) and Peroxisome proliferator-activated receptor gamma (PPAR-γ) expression in colorectal carcinoma: Relation to the available clinicopathological parameters
by: Asmaa E. Bedeer, et al.
Published: (2023-07-01)

Role of the Peroxisome Proliferator-Activated Receptors, Adenosine Monophosphate-Activated Kinase, and Adiponectin in the Ovary
by: Joëlle Dupont, et al.
Published: (2008-01-01)